Keyword: Alzheimer's Association
The company says its new name aligns with its focus on developing regenerative therapies for diseases such as Alzheimer’s and Parkinson’s.
Biogen and Eisai revealed data showing their amyloid-fighting antibody significantly slowed cognitive decline and amyloid buildup in the brain.
NIH-backed researchers found a gene mutation that may spur the decline of memory and thinking skills in people at risk for Alzheimer’s.
The U.K.’s Cytox announced it launched the research use of its variaTECT genetic biomarker test for assessing the risk of Alzheimer’s disease.